Wedbush Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.1M | Buy |
88,002
+7,465
| +9% | +$1.66M | 0.56% | 24 |
|
|
2025
Q4 | $18.4M | Buy |
80,537
+2,587
| +3% | +$589K | 0.54% | 26 |
|
|
2025
Q3 | $18M | Buy |
77,950
+747
| +1% | +$152K | 0.59% | 23 |
|
|
2025
Q2 | $14.3M | Sell |
77,203
-5,829
| -7% | -$1.08M | 0.5% | 27 |
|
|
2025
Q1 | $17.4M | Sell |
83,032
-7,200
| -8% | -$1.4M | 0.64% | 21 |
|
|
2024
Q4 | $16M | Buy |
90,232
+198
| +0.2% | +$36.4K | 0.57% | 21 |
|
|
2024
Q3 | $17.8M | Sell |
90,034
-11,759
| -12% | -$2.19M | 0.66% | 19 |
|
|
2024
Q2 | $17.5M | Buy |
101,793
+4,165
| +4% | +$690K | 0.62% | 19 |
|
|
2024
Q1 | $17.8M | Buy |
97,628
+4,484
| +5% | +$773K | 0.66% | 19 |
|
|
2023
Q4 | $14.4M | Sell |
93,144
-4,978
| -5% | -$726K | 0.64% | 20 |
|
|
2023
Q3 | $14.6M | Buy |
98,122
+2,458
| +3% | +$361K | 0.73% | 17 |
|
|
2023
Q2 | $12.9M | Sell |
95,664
-17,229
| -15% | -$2.53M | 0.61% | 20 |
|
|
2023
Q1 | $18M | Sell |
112,893
-170
| -0.2% | -$26K | 0.9% | 12 |
|
|
2022
Q4 | $18.3M | Buy |
113,063
+805
| +0.7% | +$123K | 1% | 12 |
|
|
2022
Q3 | $15.1M | Buy |
112,258
+2,068
| +2% | +$297K | 0.85% | 15 |
|
|
2022
Q2 | $16.9M | Sell |
110,190
-1,769
| -2% | -$270K | 0.92% | 10 |
|
|
2022
Q1 | $18.1M | Sell |
111,959
-5,401
| -5% | -$785K | 0.83% | 13 |
|
|
2021
Q4 | $15.9M | Buy |
117,360
+2,115
| +2% | +$250K | 0.68% | 15 |
|
|
2021
Q3 | $12.4M | Buy |
115,245
+2,911
| +3% | +$333K | 0.59% | 22 |
|
|
2021
Q2 | $12.7M | Buy |
112,334
+1,303
| +1% | +$147K | 0.6% | 22 |
|
|
2021
Q1 | $12M | Buy |
111,031
+14,438
| +15% | +$1.54M | 0.67% | 17 |
|
|
2020
Q4 | $10.3M | Buy |
96,593
+5,781
| +6% | +$556K | 0.91% | 13 |
|
|
2020
Q3 | $7.95M | Buy |
90,812
+1,252
| +1% | +$118K | 0.76% | 17 |
|
|
2020
Q2 | $8.79M | Buy |
89,560
+11,754
| +15% | +$1.03M | 0.83% | 13 |
|
|
2020
Q1 | $5.93M | Buy |
77,806
+1,143
| +1% | +$97.4K | 0.71% | 21 |
|
|
2019
Q4 | $6.79M | Buy |
76,663
+2,615
| +4% | +$217K | 0.6% | 25 |
|
|
2019
Q3 | $5.61M | Buy |
74,048
+10,183
| +16% | +$698K | 0.55% | 27 |
|
|
2019
Q2 | $4.64M | Buy |
63,865
+3,100
| +5% | +$244K | 0.47% | 38 |
|
|
2019
Q1 | $4.9M | Sell |
60,765
-11,937
| -16% | -$977K | 0.53% | 32 |
|
|
2018
Q4 | $6.7M | Buy |
72,702
+2,300
| +3% | +$202K | 0.86% | 18 |
|
|
2018
Q3 | $6.66M | Buy |
70,402
+782
| +1% | +$74.2K | 0.76% | 19 |
|
|
2018
Q2 | $6.45M | Buy |
69,620
+3,960
| +6% | +$387K | 0.8% | 16 |
|
|
2018
Q1 | $6.21M | Sell |
65,660
-529
| -0.8% | -$58.1K | 0.81% | 16 |
|
|
2017
Q4 | $6.4M | Sell |
66,189
-7,984
| -11% | -$752K | 0.78% | 17 |
|
|
2017
Q3 | $6.59M | Sell |
74,173
-3,838
| -5% | -$292K | 0.86% | 17 |
|
|
2017
Q2 | $5.66M | Buy |
78,011
+3,526
| +5% | +$237K | 0.73% | 19 |
|
|
2017
Q1 | $4.85M | Sell |
74,485
-1,901
| -2% | -$120K | 0.66% | 21 |
|
|
2016
Q4 | $4.78M | Sell |
76,386
-11,756
| -13% | -$718K | 0.7% | 20 |
|
|
2016
Q3 | $5.56M | Buy |
88,142
+13,635
| +18% | +$883K | 0.83% | 13 |
|
|
2016
Q2 | $4.61M | Buy |
74,507
+6,537
| +10% | +$398K | 0.76% | 16 |
|
|
2016
Q1 | $3.88M | Buy |
67,970
+9,799
| +17% | +$546K | 0.67% | 22 |
|
|
2015
Q4 | $3.45M | Buy |
58,171
+11,976
| +26% | +$690K | 0.62% | 23 |
|
|
2015
Q3 | $2.51M | Buy |
46,195
+7,086
| +18% | +$461K | 0.5% | 30 |
|
|
2015
Q2 | $2.63M | Buy |
39,109
+10,353
| +36% | +$676K | 0.48% | 29 |
|
|
2015
Q1 | $1.68M | Buy |
28,756
+5,761
| +25% | +$348K | 0.29% | 77 |
|
|
2014
Q4 | $1.5M | Buy |
22,995
+1,335
| +6% | +$84.2K | 0.23% | 89 |
|
|
2014
Q3 | $1.25M | Buy |
21,660
+3,008
| +16% | +$167K | 0.19% | 102 |
|
|
2014
Q2 | $1.05M | Sell |
18,652
-1,256
| -6% | -$65.9K | 0.17% | 122 |
|
|
2014
Q1 | $1.02M | Buy |
19,908
+849
| +4% | +$42.9K | 0.18% | 129 |
|
|
2013
Q4 | $1.01M | Sell |
19,059
-411
| -2% | -$20.2K | 0.24% | 105 |
|
|
2013
Q3 | $871K | Buy |
19,470
+50
| +0.3% | +$2.22K | 0.23% | 113 |
|
|
2013
Q2 | $803K | Buy |
+19,420
| New | +$849K | 0.22% | 115 |
|
Other funds holding ABBV
VCM
VPM
Wedbush Securities's ABBV Position: Q1 2026 in Review
Wedbush Securities increased its AbbVie (ABBV) stake by 9.3% in Q1 2026, buying an estimated $1.66M and bringing the position to 88,002 shares worth $19.1M. The position accounts for 0.56% of the portfolio, ranked #24.
Wedbush Securities first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Wedbush Securities held 88,002 shares of AbbVie worth $19.1M as of Q1 2026.
- Wedbush Securities bought 7,465 AbbVie shares in Q1 2026, an estimated $1.66M.
- AbbVie made up 0.56% of Wedbush Securities's portfolio in Q1 2026, its #24 holding.
- Wedbush Securities first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.